Brief: Enanta Pharmaceuticals Q2 Revenue USD 17.054 Million Vs. IBES Estimate USD 16.5 Million
06/05/2024 21:01
May 06 (Reuters) - Enanta Pharmaceuticals Q2 pretax profit USD -31.52 million. * Q2 operating income USD -32.766 million * Q2 operating expenses USD 49.82 million * Q2 net income USD -31.157 million vs. IBES estimate USD -28 million
Recent news on Enanta Pharmaceuticals
See all newsEnanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royalties
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Enanta Pharmaceuticals Q1 revenue beats estimates